Relay Plus Thoracic Stent-Graft System 28-M334145302390URecalls & reported problems
Bolton Medical Inc. · Endovascular stent-graft system · Class 3 · Implant
Data updated Oct 18, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 1
- Deaths reported
- 0
- Injuries reported
- 0
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 08435761002192), received between Sep 27, 2024 and Sep 27, 2024 — classified as 1 malfunction.
The most frequently reported specific device problem is “Difficult to Advance” (1 report).
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.
Reports received per month
Most reported problems
Device problems
- Difficult to Advance1
- Failure to Advance1
- Premature Activation1
Patient problems
- No Clinical Signs, Symptoms or Conditions1
Recent adverse event reports
The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.
MalfunctionSep 27, 2024Premature Activation; Failure to Advance; Difficult to Advance; Premature Activation; Failure to Advance; Difficult to Advance
"UNABLE TO ADVANCE THE INNER SHEATH: THE DELIVERY SYSTEM WAS ADVANCED INTO THE ARTERY AND THEN THE INNER SHEATH WAS ATTEMPTED TO BE ADVANCED OUT OF THE OUTER SHEATH. HOWEVER, THE INNER SHEATH WAS UNABLE TO PASS THROUGH THE UPPER PART OF THE CURVATURE OF THE AORTIC ARCH. PUSH-PULL MANIPULATION AND ROTATIONAL TORQUE WERE APPLIED, BUT THE INNER SHEATH WAS UNABLE TO BE PASSED THROUGH. THE PHYSICIAN CONSIDERED PERFORMING A PULL-THROUGH TECHNIQUE WITH THE DELIVERY SYSTEM KEPT IN THE AORTA, BUT DECIDED NOT TO PROCEED FURTHER AS IT WAS OBSERVED THAT THE INNER SHEATH HAD ALREADY BEEN PULLED DOWN SLIGHTLY, ALTHOUGH THE PROXIMAL STENT HAD NOT YET BEEN RELEASED. THE DELIVERY SYSTEM WAS ABLE TO BE SUCCESSFULLY REMOVED FROM THE PATIENT WITH THE AID OF THE LARGE ACCESS VESSEL, ALTHOUGH THE INNER SHEATH HAD ALREADY BEEN ADVANCED OUT OF THE OUTER SHEATH. OBSERVATION OF THE REMOVED DELIVERY SYSTEM REVEALED THAT THE INNER SHEATH HAD BEEN PULLED DOWN SLIGHTLY AND THE BARE STENT WAS EXPOSED, AS SPECULATED. AS THE DESCENDING AORTA WAS SIGNIFICANTLY TORTUOUS IN AN S-SHAPE AND THE UPPER PART OF THE CURVED AORTIC ARCH WAS QUITE NARROW, A PULL-THROUGH TECHNIQUE WAS PERFORMED TO ALLOW THE DELIVERY SYSTEM OF
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 20327279 ↗
Other System, Endovascular Graft, Aortic Aneurysm Treatment devices
- Endurant® IIs ESBF2814C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls34 deaths254 reports
- Endurant® IIs ESBF3214C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls19 deaths173 reports
- Endurant® IIs ESBF3614C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT1 recall37 deaths214 reports
- Endurant® IIs ESBF2514C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls18 deaths136 reports
- Endurant® IIs ESBF2314C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls9 deaths60 reports
- RelayPro Thoracic Stent-Graft System 28-N4-34-154-34UBolton Medical Inc. · System, Endovascular Graft, Aortic Aneurysm Treatment3 recalls7 reports
- Vela Proximal Endograft System A34-34/C100-O20 VEndologix LLC · System, Endovascular Graft, Aortic Aneurysm Treatment3 deaths152 reports
- Endurant® II ETCF2828C49EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls7 deaths44 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 18, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page